Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute myelogenous leukemia in 1st remission.

@article{Gale1999DelphipanelAO,
  title={Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute myelogenous leukemia in 1st remission.},
  author={Robert Peter Gale and Robert E. Park and Robert W. Dubois and Geoffrey P. Herzig and William Gray Hocking and Mary M. Horowitz and Armand Keating and Sanford Jay Kempin and Charles A. Linker and Charles A Schiffer and Peter H. Wiernik and Daniel J. Weisdorf and Kanti R Rai},
  journal={Leukemia research},
  year={1999},
  volume={23 8},
  pages={709-18}
}
BACKGROUND Despite considerable data, there is still controversy over which adults with acute myelogenous leukemia (AML) in 1st remission should receive high-dose therapy and a bone marrow transplant rather than conventional-dose chemotherapy. Analyses of data from randomized trials are complex, conclusions sometimes contradictory and results not sufficiently detailed to allow subject-level decisions. OBJECTIVE To determine appropriate use of high-dose therapy and bone marrow transplants in… CONTINUE READING
6 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-6 of 6 extracted citations

Similar Papers

Loading similar papers…